Skip to main content
Micro-Tech (Nanjing) Co.,Ltd logo

Micro-Tech (Nanjing) Co.,Ltd — Investor Relations & Filings

Ticker · 688029 ISIN · CNE100003MG1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2024-02-04 Transaction in Own Shar…
Country CN China
Listing Shanghai Stock Exchange 688029

About Micro-Tech (Nanjing) Co.,Ltd

https://www.micro-tech.com.cn/

Micro-Tech (Nanjing) Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical devices. The company focuses on providing advanced solutions for gastroenterology, respiratory medicine, and orthopedics. Its product portfolio includes a wide range of endoscopic diagnostic and therapeutic tools such as biopsy forceps, disposable hemoclips, biliary and esophageal stents, and specialized instruments for Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD). Micro-Tech emphasizes innovation and quality, maintaining international certifications to serve a global healthcare market. By integrating precision engineering with clinical needs, the company aims to improve patient outcomes and procedural efficiency for medical professionals worldwide.

Recent filings

Filing Released Lang Actions
南微医学科技股份有限公司第三届董事会第十八次会议决议公告
Transaction in Own Shares Classification · 95% confidence The document is a board meeting resolution announcement from 南微医学科技股份有限公司, detailing the approval of a share repurchase plan. It includes voting results and references a separate announcement for the share repurchase plan. The document is short (658 characters) and focuses on board decisions rather than full financial data or detailed reports. It is not an annual or interim report, nor a regulatory certification. The key content is about the company's plan to buy back shares, which fits the category of Transaction in Own Shares (POS).
2024-02-04 Chinese
南微医学科技股份有限公司关于推动公司“提质增效重回报”暨以集中竞价交易方式回购公司股份方案的公告
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement from 南微医学科技股份有限公司 regarding a share repurchase (stock buyback) plan. It includes specifics about the purpose, amount, price, duration, authorization, and risks of the share repurchase. The text repeatedly mentions the company's plan to buy back shares using its own funds through centralized bidding, the intended use of repurchased shares for employee stock ownership plans or equity incentives, and the procedural and regulatory compliance aspects. There is no indication that this is a full financial report, earnings release, or management discussion. Instead, it is a formal announcement about a capital action involving the company's own shares. This fits the definition of a Transaction in Own Shares (POS) filing, which covers share repurchase announcements and related details.
2024-02-04 Chinese
南微医学科技股份有限公司关于维护公司股价稳定暨收到董事长提议回购公司股份的提示性公告
Transaction in Own Shares Classification · 100% confidence The document is a public announcement from the company 南微医学科技股份有限公司 regarding a proposal by the chairman to repurchase company shares. It details the reasons, methods, amount, and conditions of the proposed share buyback. The text does not contain financial statements or detailed financial results but focuses on the company's plan to repurchase shares to stabilize stock price and implement employee incentive plans. This fits the definition of a Transaction in Own Shares (POS) filing, which reports on share repurchase activities. The document length is short (1356 characters), and it is not an announcement of a report publication but a substantive announcement of a share repurchase proposal.
2024-01-30 Chinese
江苏新高的律师事务所关于南微医学2024年第一次临时股东大会的见证法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the legitimacy of the convening, attendance, voting procedures, and results of a company's 2024 first extraordinary general meeting (临时股东大会). It details the legal compliance of the meeting process, attendance, and voting results but does not contain financial data or report content itself. The document is a legal witness opinion on the shareholder meeting, not the meeting materials or voting results announcement themselves. Given the nature of the document as a legal opinion on the shareholder meeting, it fits best under Regulatory Filings (RNS) as it is a compliance/legal attestation document rather than a report or announcement of voting results.
2024-01-12 Chinese
南微医学科技股份有限公司2024年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement from the company's first extraordinary general meeting of shareholders in 2024. It details the meeting date, attendance, voting results on specific proposals, and legal witness statements confirming the validity of the meeting and resolutions. There is no indication that this is a full annual or interim report, audit report, or earnings release. Instead, it is an official announcement of the voting results from a shareholders' meeting. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document length is short and focused on voting outcomes, not a report publication or regulatory filing. Therefore, the correct classification is DVA with high confidence.
2024-01-12 Chinese
南微医学科技股份有限公司2024年第一次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled '2024 年第一次临时股东大会会议资料' which translates to '2024 First Extraordinary General Meeting (EGM) Meeting Materials'. It contains detailed meeting instructions, agenda, and a specific proposal for shareholder approval regarding related party transactions for 2024. The content is typical of materials prepared and distributed for a shareholders' meeting to inform and guide attendees on the meeting process and agenda items. The document length is 3824 characters, which is relatively short and consistent with meeting materials rather than a full report. There is no financial statement or detailed financial analysis present, so it is not an Annual Report (10-K) or Interim Report (IR). It is not a voting results announcement (DVA) because it does not contain voting outcomes, only the agenda and materials for the meeting. It is not a Proxy Solicitation (PSI) because it does not solicit votes but provides meeting information. Therefore, the document best fits the category of AGM Information (AGM-R), which includes presentations and materials shared during the Annual or Extraordinary General Meeting.
2024-01-04 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.